← Leaderboards
Kirkwood A Pritchard
Medical College Of Wisconsin
$11,465,509
Attributed
$14,821,264
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$14,821,264 · 8
By mechanism
R01$13,971,612 · 6
R21$849,652 · 2
Top collaborators
- Cheryl A Hillery8 shared
- Mary G Sorci-Thomas5 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Cheryl A Hillery$7,803,742
Others in their field
Top investigators on “Vasodilation”
- Jonathan H Jaggar · University Of Tennessee Health Sci Ctr$16,366,261
- Claudia R Morris · Children'S Hospital &Res Ctr At Oakland$12,637,198
- William Bryson Campbell · Medical College Of Wisconsin$12,032,862
- Nabil J. Alkayed · Johns Hopkins University$11,563,230
- Noyan Gokce · Boston Medical Center$11,131,138
- Alejandro M Dopico · University Of Tennessee Health Sci Ctr$10,559,053
Research focus
VasodilationOxidative StressReportingDesignInflammatoryMediatingPeroxidasesInflammationPlayEnzymesBaseNitric OxideBlood VesselsPropertyPathway InteractionsCellsInjurySickle Cell AnemiaVascular DiseasesHemoglobinEndothelial CellsSicklingStrokeXanthine Oxidase
Grant awards (37)
Mechanisms of Inflammation in Sickle Cell Disease$539,426
R01 · FY2024 · HL · contact PI
Mechanisms of Inflammation in Sickle Cell Disease$550,435
R01 · FY2023 · HL · contact PI
Mechanisms of Inflammation in Sickle Cell Disease$550,435
R01 · FY2022 · HL · contact PI
Mechanisms of Inflammation in Sickle Cell Disease$550,435
R01 · FY2021 · HL · contact PI
Mechanisms of Inflammation in Sickle Cell Disease$504,576
R01 · FY2019 · HL · contact PI
Trifunctional Peptides for Targeting the Ischemic Cascade$240,855
R21 · FY2019 · NS · contact PI
Mechanisms of Inflammation in Sickle Cell Disease$505,699
R01 · FY2018 · HL · contact PI
Trifunctional Peptides for Targeting the Ischemic Cascade$196,297
R21 · FY2018 · NS · contact PI
Mechanisms of Inflammation in Sickle Cell Disease$506,790
R01 · FY2017 · HL · contact PI
Mechanisms of Inflammation in Sickle Cell Disease$520,851
R01 · FY2016 · HL · contact PI
Biophysics of HDL Dysfunction$591,775
R01 · FY2015 · HL · contact PI
Biophysics of HDL Dysfunction$643,959
R01 · FY2014 · HL · contact PI
Biophysics of HDL Dysfunction$628,118
R01 · FY2013 · HL · contact PI
Asthma Increases Vaso-occlusion in Sickle Cell Disease$486,519
R01 · FY2013 · HL · contact PI
Biophysics of HDL Dysfunction$18,866
R01 · FY2013 · HL · contact PI
Biophysics of HDL Dysfunction$633,807
R01 · FY2012 · HL · contact PI
Asthma Increases Vaso-occlusion in Sickle Cell Disease$511,048
R01 · FY2012 · HL · contact PI
Novel Peptide MPO Inhibitors for Treating Atherosclerosis$225,000
R21 · FY2012 · HL · contact PI
Asthma Increases Vaso-occlusion in Sickle Cell Disease$512,673
R01 · FY2011 · HL · contact PI
Novel Peptide MPO Inhibitors for Treating Atherosclerosis$187,500
R21 · FY2011 · HL · contact PI
Asthma Increases Vaso-occlusion in Sickle Cell Disease$646,830
R01 · FY2010 · HL · contact PI
HDL Dysfunction and Vascular Inflammation$367,766
R01 · FY2010 · HL · contact PI
HDL Dysfunction and Vascular Inflammation$367,766
R01 · FY2009 · HL · contact PI
HDL Dysfunction and Vascular Inflammation$367,766
R01 · FY2008 · HL · contact PI
HDL Dysfunction and Vascular Inflammation$367,766
R01 · FY2007 · HL · contact PI
HDL Dysfunction and Vascular Inflammation$378,750
R01 · FY2006 · HL · contact PI
Native LDL, Cholesterol and Impaired Vasodilation$292,950
R01 · FY2006 · HL · contact PI
Hsp90 Mediates eNOS and Vascular Function$300,000
R01 · FY2005 · HL
Native LDL, Cholesterol and Impaired Vasodilation$300,000
R01 · FY2005 · HL
Hsp90 Mediates eNOS and Vascular Function$300,000
R01 · FY2004 · HL
Native LDL, Cholesterol and Impaired Vasodilation$300,000
R01 · FY2004 · HL
Native LDL, Cholesterol and Impaired Vasodilation$358,500
R01 · FY2003 · HL
Hsp90 Mediates eNOS and Vascular Function$300,000
R01 · FY2003 · HL
Hsp90 Mediates eNOS and Vascular Function$300,000
R01 · FY2002 · HL
NATIVE LDL, CHOLESTEROL AND IMPAIRED VASORELAXATION$263,640
R01 · FY2002 · HL
NATIVE LDL, CHOLESTEROL AND IMPAIRED VASORELAXATION$255,960
R01 · FY2001 · HL
NATIVE LDL, CHOLESTEROL AND IMPAIRED VASORELAXATION$248,506
R01 · FY2000 · HL